Insider Trading28 Sept 2026, 06:30 pm
Alembic Pharma Closes Trading Window for Q2/H1 FY27 Results
AI Summary
Alembic Pharmaceuticals Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will be shut from October 1, 2026, until 48 hours after the declaration of the company's unaudited financial results for the quarter and half-year ending September 30, 2026. This measure is standard practice to prevent potential insider trading ahead of financial result announcements.
Key Highlights
- Trading window closure announced by Alembic Pharmaceuticals.
- Effective from October 1, 2026.
- Closure is for designated persons and immediate relatives.
- Duration is until 48 hours post Q2/H1 FY27 results declaration.
- Aims to prevent insider trading as per SEBI regulations.
Price Impact
More from APLLTD